All-transretinoic acid followed by intensive chemotherapy gives a high complete remission rate and may prolong remissions in newly diagnosed acute promyelocytic leukemia: a pilot study on 26 casesPierre Fenaux, F. Maloisel, Sylvie Castaigné et al.|Blood|1992Cited by 235
Rituximab and dose-dense chemotherapy for adults with Burkitt's lymphoma: a randomised, controlled, open-label, phase 3 trialVincent Ribrag, Gilles Salles, Serge Koscielny et al.|The Lancet|2016Cited by 190
Treatment of newly diagnosed acute promyelocytic leukemia (APL): a comparison of French-Belgian-Swiss and PETHEMA resultsLionel Adès, Pierre Fenaux, Miguel Á. Sanz et al.|Blood|2007Cited by 157
Prognostic implication of FLT3 and Ras gene mutations in patients with acute promyelocytic leukemia (APL): a retrospective study from the European APL GroupCéline Callens, Sylvie Chevret, JM Cayuela et al.|Leukemia|2005Cited by 139
Pediatric-Like Acute Lymphoblastic Leukemia Therapy in Adults With Lymphoblastic Lymphoma: The GRAALL-LYSA LL03 StudyStéphane Leprêtre, Hervé Dombret, Aurore Touzart et al.|Journal of Clinical Oncology|2015Cited by 98